Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Durability of anti-Spike antibodies in the infant after maternal COVID-19 vaccination

View ORCID ProfileLydia L. Shook, Caroline G. Atyeo, Lael M. Yonker, Alessio Fasano, Kathryn J. Gray, Galit Alter, View ORCID ProfileAndrea G. Edlow
doi: https://doi.org/10.1101/2021.11.17.21266415
Lydia L. Shook
1Massachusetts General Hospital, Department of Obstetrics & Gynecology
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lydia L. Shook
Caroline G. Atyeo
2Ragon Institute of MGH, MIT, and Harvard
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lael M. Yonker
3Massachusetts General Hospital, Department of Pediatrics
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessio Fasano
3Massachusetts General Hospital, Department of Pediatrics
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn J. Gray
4Brigham and Women’s Hospital, Department of Obstetrics & Gynecology
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Galit Alter
2Ragon Institute of MGH, MIT, and Harvard
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: AEDLOW@MGH.HARVARD.EDU GALTER@MGH.HARVARD.EDU
Andrea G. Edlow
1Massachusetts General Hospital, Department of Obstetrics & Gynecology
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea G. Edlow
  • For correspondence: AEDLOW@MGH.HARVARD.EDU GALTER@MGH.HARVARD.EDU
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

COVID-19 vaccination in pregnancy generates functional anti-Spike IgG antibodies that are known to cross the placenta. However, the durability of vaccine-induced maternal anti-S IgG in infant circulation, and how it compares to durability of antibody from maternal natural infection, is unknown. We quantified anti-S IgG in 92 2-month and 6-month-old infants whose mothers were vaccinated in pregnancy, and in 12 6-month-old infants after maternal natural infection with SARS-CoV-2. In the vaccinated group, 94% (58/62) of infants had detectable anti-S IgG at 2 months, and 60% (18/30) had detectable antibody at 6 months. In contrast, 8% (1/12) of infants born to women infected with SARS-CoV-2 in pregnancy had detectable anti-S IgG at the 6-month timepoint. Vaccination resulted in significantly higher maternal and cord titers at delivery and significantly greater antibody persistence in infants at 6 months, compared to natural infection.

Competing Interest Statement

K.J.G. has consulted for Illumina, BillionToOne, and Aetion outside the scope of the submitted work. G.A. is the founder of Seromyx Inc. A.F. reported serving as a cofounder of and owning stock in Alba Therapeutics and serving on scientific advisory boards for NextCure and Viome outside the submitted work. All other authors report no competing interests.

Funding Statement

This study was funded by: NICHD: 1R01HD100022-01 and 3R01HD100022-02S2 to A.G.E.; 1K12HD103096 to L.L.S.; March of Dimes Grant 6-FY20-223 to A.G.E.; NIH/NHLBI: K08HL1469630-03 and 3K08HL146963-02S1 to K.J.G. and 5K08HL143183 to L.M.Y; Ragon Institute of MGH, MIT, and Harvard and the MGH ECOR Scholars award to G.A.; Nancy Zimmerman, Samana Kay MGH Research Scholars award to G.A.; NIAID: 3R37AI080289-11S1, R01AI146785, U19AI42790-01, U19AI135995-02, 1U01CA260476-01, and CIVIC5N93019C00052 to G.A.; the Gates Foundation Global Health Vaccine Accelerator Platform funding: OPP1146996 and INV-001650 to G.A.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The IRB of MassGeneral Brigham gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 20, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Durability of anti-Spike antibodies in the infant after maternal COVID-19 vaccination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Durability of anti-Spike antibodies in the infant after maternal COVID-19 vaccination
Lydia L. Shook, Caroline G. Atyeo, Lael M. Yonker, Alessio Fasano, Kathryn J. Gray, Galit Alter, Andrea G. Edlow
medRxiv 2021.11.17.21266415; doi: https://doi.org/10.1101/2021.11.17.21266415
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Durability of anti-Spike antibodies in the infant after maternal COVID-19 vaccination
Lydia L. Shook, Caroline G. Atyeo, Lael M. Yonker, Alessio Fasano, Kathryn J. Gray, Galit Alter, Andrea G. Edlow
medRxiv 2021.11.17.21266415; doi: https://doi.org/10.1101/2021.11.17.21266415

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Obstetrics and Gynecology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1748)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2783)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (555)
  • Occupational and Environmental Health (597)
  • Oncology (1457)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)